India still heavily reliant on China for life saving drugs despite PLI booster: Report

[beijingwalker]

India still heavily reliant on China for life saving drugs despite PLI booster: Report​

India still heavily reliant on China for life saving drugs despite PLI booster: Report

By Surabhi Sarda,
Aug 04, 2023, 06:19 PM

Synopsis

India's pharma industry is heavily dependent on China for bulk drug imports, with 43% of total pharma imports originating from China, according to a report by CareEdge. Moreover, the use of bulk drugs from China has increased from 64% in fiscal year 2014 to 71% in FY23, the report added.​

Among India’s overall pharma imports, bulk drugs continue to contribute 55-66 per cent and dependency on China for the same is expected to remain high in the coming years, report from CareEdge showed on Friday.

The report revealed that India's 43 per cent of total pharma imports are from China, indicating a heavy dependency and raising concerns due to the on-going geopolitical tensions between the two Asian countries.


"The contribution of bulk drug imports from China has exhibited significant growth in both value and volume terms, increasing from 64% and 62% during FY14 to 71% and 75% during FY23, respectively," the report said.

The Indian pharmaceutical industry is estimated to grow at 7 to 8 per cent in FY24-FY25. The bulk drug imports too have witnessed a steady Compound Annual Growth Rate (CAGR) of about 7%, reflecting the industry’s growing reliance on these essential components.

Dependency for life saving drugs​

New Delhi is dependent on China particularly for life saving drugs. “This situation raises legitimate concerns about the availability, cost, and uninterrupted supply of crucial medicines in India's healthcare landscape,” the report said.

India's dependency on Key Starting Materials (KSM) from Beijing exceeds 50%.

India also imports certain formulations which account to 30 per cent to 35 per cent along Ayush and Herbal, and Surgical products, accounting to the rest. However, the imports of these is diversified.

India still heavily reliant on China for life saving drugs despite PLI booster: Report

India's pharma industry is heavily dependent on China for bulk drug imports, with 43% of total pharma imports originating from China, according to a report by CareEdge. Moreover, the use of bulk drugs from China has increased from 64% in fiscal year 2014 to 71% in FY23, the report added.

economictimes.indiatimes.com

 

[CallSignMaverick]

Demand for Indian generic drugs skyrockets in China amid massive Covid surge

China's National Health Security Administration said on Sunday that Pfizer's Paxlovid oral medication, which is used to treat Covid-19, could not be included in the "register of drugs in the basic medical insurance", because the company's quotation was too high, media reports here said.

economictimes.indiatimes.com

 

[Path-Finder]

India still heavily reliant on China for life saving drugs despite PLI booster: Report​

India still heavily reliant on China for life saving drugs despite PLI booster: Report

By Surabhi Sarda,
Aug 04, 2023, 06:19 PM

Synopsis

India's pharma industry is heavily dependent on China for bulk drug imports, with 43% of total pharma imports originating from China, according to a report by CareEdge. Moreover, the use of bulk drugs from China has increased from 64% in fiscal year 2014 to 71% in FY23, the report added.​

Among India’s overall pharma imports, bulk drugs continue to contribute 55-66 per cent and dependency on China for the same is expected to remain high in the coming years, report from CareEdge showed on Friday.

The report revealed that India's 43 per cent of total pharma imports are from China, indicating a heavy dependency and raising concerns due to the on-going geopolitical tensions between the two Asian countries.


"The contribution of bulk drug imports from China has exhibited significant growth in both value and volume terms, increasing from 64% and 62% during FY14 to 71% and 75% during FY23, respectively," the report said.

The Indian pharmaceutical industry is estimated to grow at 7 to 8 per cent in FY24-FY25. The bulk drug imports too have witnessed a steady Compound Annual Growth Rate (CAGR) of about 7%, reflecting the industry’s growing reliance on these essential components.

Dependency for life saving drugs​

New Delhi is dependent on China particularly for life saving drugs. “This situation raises legitimate concerns about the availability, cost, and uninterrupted supply of crucial medicines in India's healthcare landscape,” the report said.

India's dependency on Key Starting Materials (KSM) from Beijing exceeds 50%.

India also imports certain formulations which account to 30 per cent to 35 per cent along Ayush and Herbal, and Surgical products, accounting to the rest. However, the imports of these is diversified.

India still heavily reliant on China for life saving drugs despite PLI booster: Report

India's pharma industry is heavily dependent on China for bulk drug imports, with 43% of total pharma imports originating from China, according to a report by CareEdge. Moreover, the use of bulk drugs from China has increased from 64% in fiscal year 2014 to 71% in FY23, the report added.

economictimes.indiatimes.com

pleaj stop poshting fake newj.

 

[beijingwalker]

pleaj stop poshting fake newj.

Which part is fake?

Demand for Indian generic drugs skyrockets in China amid massive Covid surge

China's National Health Security Administration said on Sunday that Pfizer's Paxlovid oral medication, which is used to treat Covid-19, could not be included in the "register of drugs in the basic medical insurance", because the company's quotation was too high, media reports here said.

economictimes.indiatimes.com

Covid was long over

 

[Path-Finder]

Which part is fake?

come on man, it was sarcasm.

 

[beijingwalker]

Made in China keeps hundreds of millions Americans and Indians alive

U.S. dependence on China for lifesaving drugs grows

Treatments for cancer, cardiovascular diseases drive rising imports

asia.nikkei.com

India still heavily reliant on China for life saving drugs despite PLI booster: Report

India's pharma industry is heavily dependent on China for bulk drug imports, with 43% of total pharma imports originating from China, according to a report by CareEdge. Moreover, the use of bulk drugs from China has increased from 64% in fiscal year 2014 to 71% in FY23, the report added.

economictimes.indiatimes.com

 

[ProudThamizhan]

As long as Chinese suppliers keep up the rqd stds and make the pricing attractive , why not ? Nobody said you should work only for Walmart

 

[GamoAccu]

China beat and embarrassed India in Galwan clash, and the imports keep going up.Indians are shameless people. These people have no integrity, loyalty, or pride. No wonder they were so easy to colonize by the British and Mughal.